Non-Hodgkin's Lymphoma Clinical Trials Non-Hodgkin's Lymphoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
Condition:   Non-Hodgkin Lymphoma, B-cell Intervention:   Drug:  " novel "  MAB (alone or in combination) Sponsors:   Fondazione Italiana Linfomi - ETS;   Roche Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials

Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Condition:   Non-hodgkin Lymphoma Intervention:   Drug: CD38-SADA:177Lu-DOTA Complex Sponsor:   Y-mAbs Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Condition:   B-cell Non Hodgkin Lymphoma Interventions:   Drug: Odronextamab;   Drug: Loncastuximab tesirine;   Drug: Rituximab;   Drug: Ifosfamide;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Etoposide Phosphate;   Drug: Dexamethasone;   Biological: CAR T-cells (TBC) Sponsors:   University of Birmingham;   Cancer Research UK;   Fight Kids Cancer;   Regeneron Pharmaceuticals;   ADC Therapeutics SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials